.svg){kind=small}
Sep-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the Massachusetts cannabis market, Apotho Therapeutics has shown notable fluctuations in its category rankings over recent months. Specifically, in the Flower category, the brand did not secure a position within the top 30 from June to September 2025, indicating a potential area for growth or increased competition in this segment. Conversely, their performance in the Pre-Roll category has been more dynamic. Starting at rank 47 in June, they experienced a slight dip to 58 in July but made a significant recovery by September, climbing to rank 20. This upward movement suggests a strengthening presence or successful strategy in the Pre-Roll market.
Examining the sales trends, Apotho Therapeutics has demonstrated a robust growth trajectory in the Pre-Roll category within Massachusetts. From July to September, there was a marked increase in sales, culminating in a substantial sales figure of over $317,000 in September. This suggests an effective market penetration or consumer preference shift towards their Pre-Roll offerings. However, the absence of rankings in the Flower category throughout the same period highlights a potential challenge or strategic gap that the brand might need to address to enhance its overall market presence. This mixed performance across categories underscores the importance of targeted strategies to capitalize on growth opportunities while addressing areas of underperformance.
Competitive Landscape
In the competitive landscape of the Massachusetts Pre-Roll category, Apotho Therapeutics has demonstrated a significant upward trajectory in recent months. After starting at rank 47 in June 2025, Apotho Therapeutics impressively climbed to rank 20 by September 2025, indicating a substantial improvement in market positioning. This rise is particularly notable when compared to competitors such as Fernway, which experienced a decline from rank 11 in June to falling out of the top 20 by September, and Native Sun, which fluctuated but ultimately improved to rank 19. Meanwhile, Green Gold Group showed consistent improvement, moving from rank 50 to 22, and Tower Three maintained a steady presence around the 18th position. The upward movement of Apotho Therapeutics suggests a successful strategy in capturing market share, potentially driven by increased consumer preference or effective marketing efforts, positioning it as a brand to watch in the Massachusetts Pre-Roll market.
Notable Products
In September 2025, Golden Pupil Pre-Roll (1g) maintained its top position as the leading product for Apotho Therapeutics, with sales reaching 4,357 units. Candy Milk Pre-Roll (1g) emerged as the second best-selling product, showing a strong debut in the rankings. Daily Grape Pre-Roll (1g) improved its standing from fourth place in June 2025 to third place in September, matching the sales figures of Tokyo Snow Pre-Roll (1g). Tokyo Snow Pre-Roll (1g) also debuted in the third position, indicating a competitive tie with Daily Grape. Blue Dream Pre-Roll (1g) rounded out the top five, securing the fourth spot, demonstrating a consistent performance since its introduction.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
